Abstract: The invention relates to an apparatus for measuring stereovision comprising: a frame body having a space therein; a 3D display unit which is arranged on the upper part of the frame body and which display a 3D image downwards through the space; a reflective mirror which is arranged on the lower part of the frame body and which reflects the 3D image displayed from the 3D display unit in a forward direction; an eyepiece which is arranged between the 3D display unit and the reflective mirror on the rear part of the frame body and through which a 3D image is seen; a half mirror by which the 3D image reflected forward by the reflective mirror is penetrated and reflected and which is rotatably installed on the frame body to adjust a reflection angle upward or downward; a stage which is arranged in front of the half mirror, a plurality of protrusion degree markers having a predetermined protrusion degree being arranged on the bottom surface successively with a predetermined distance, a target being installed on the s

Abstract: A method for treating an angiogenesis-mediated eye disease, includes administering to a subject in need thereof an effective amount of EC-SOD protein, or a vector having a polynucleotide encoding the EC-SOD protein, to treat angiogenesis-mediated eye diseases.

Abstract: A composition for preventing or treating a viral infection, which includes an ethanol extract of Tetracera scandens as an effective component, is provided. The composition exhibits low toxicity and few side effects and effectively inhibits reverse transcriptase activities to suppress synthesis of DNA, and thus can be useful in preventing or treating infections caused by various kinds of RNA viruses.

Abstract: The present invention relates to tumor antigen proteins or genes derived from polo-like kinase 1. As a result of the formation of a complex by binding polo-like kinase 1-derived proteins or variants having characteristics functionally identical to the proteins with MHC class I antigens or II antigens, the complex can be recognized by cytotoxic T lymphocytes. Therefore, the polo-like kinase 1-derived proteins or variants are identified as a tumor antigen which can be generally used in tumor immunotherapy.

Abstract: A method for treating a disease, particularly asthma and anaphylactic shock, comprises administering to a subject in need thereof an effective amount of an EC-SOD protein or a vector having a polynucleotide encoding thereof.

Abstract: A pin guide for the surgical operation of an avascular necrosis of a femoral head includes a guide body having a central pin guide hole extending along a centerline of the guide body and a plurality of side pin guide holes formed so as to make a specified angle with the central pin guide hole. The side pin guide holes are radially arranged around the central pin guide hole at a front side of the guide body and joined to the central pin guide hole at a rear side of the guide body.

Abstract: The present invention relates to tumor antigen proteins or genes derived from polo-like kinase 1. As a result of the formation of a complex by binding polo-like kinase 1-derived proteins or variants having characteristics functionally identical to the proteins with MHC class I antigens or II antigens, the complex can be recognized by cytotoxic T lymphocytes. Therefore, the polo-like kinase 1-derived proteins or variants are identified as a tumor antigen which can be generally used in tumor immunotherapy.